Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 30, 2011 09:42 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces Podium Presentation of Efficacy and Clinical Safety Data for Vitaros(R) at the European Sexual Society Medicine Conference

SAN DIEGO, Nov. 30, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) announced today the selection of an oral podium presentation on Vitaros®...
November 21, 2011 09:51 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces Appointment of Dr. Kleanthis G. Xanthopoulos to Its Board of Directors

SAN DIEGO, Nov. 21, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) announced today that Kleanthis G. Xanthopoulos, Ph.D., President and Chief...
November 15, 2011 09:30 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces That Its NexACT(R) Partner Exodos Life Sciences Has Completed Its pre-IND Meeting With the FDA

SAN DIEGO, Nov. 15, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) announced today that its NexACT® out-licensing partner, Exodos Life Science...
November 14, 2011 09:47 ET | Source: Seelos Therapeutics, Inc.

Femprox(R) Phase III Clinical Data From Apricus Biosciences Chosen for a Presentation at the European Society for Sexual Medicine

SAN DIEGO, Nov. 14, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) announced today the acceptance of an abstract entitled, "Age Group Analysis of a...
November 11, 2011 13:15 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces Third Quarter 2011 Financial Results Conference Call

SAN DIEGO, Nov. 11, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) announced today that management will hold a conference call to discuss its third quarter 2011...
October 19, 2011 09:30 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces Issuance of Korean Patent, Expanding Its Patent Portfolio for Its Topical Cream to Treat Premature Ejaculation

SAN DIEGO, Oct. 19, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com) announced today that the Korean Patent Office recently...
October 13, 2011 11:15 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces New Data Published in the International Journal of Pharmaceutics Confirming Efficiency of NexACT(R) Drug Delivery Technology

SAN DIEGO, Oct. 13, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com) announced today the publication of an article in the...
October 10, 2011 10:31 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces Presentation of Efficacy and Clinical Safety Data for Vitaros(R) at Upcoming Industry Conference

SAN DIEGO, Oct. 10, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com) announced today that the submission of an abstract...
October 06, 2011 09:52 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences to Present Poster of Femprox(R) Phase III Clinical Data at Upcoming Industry Conference

SAN DIEGO, Oct. 6, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com) announced today that the submission of an abstract...
October 04, 2011 10:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences to Present NexACT(R) Technology Overview at PODD Drug Delivery Conference

SAN DIEGO, Oct. 4, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com) announced today that Dr. Richard Martin, Vice...